Cephalon Slams Bid To Reinstate Pa. Opioid Marketing Suit
A Pennsylvania appeals court was urged on Monday to affirm a decision that federal law preempted claims that off-label marketing by Cephalon Inc. of its opioid painkiller "lollipop" Actiq to treat...To view the full article, register now.
Already a subscriber? Click here to view full article